文献速递其他结缔组织病血管炎

系统性硬化症相关肺动脉高压的30天再住院:全国性研究

Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study.
PubMed 文献 · Semin Arthritis Rheum · 2021-01-08

该回顾性研究利用美国全国再住院数据库,分析2010至2015年系统性硬化症相关肺动脉高压(SSc-PH)与非SSc肺动脉高压(non-SSc PAH)住院患者的30天再住院率及特征。结果显示SSc-PH再住院率22%,non-SSc PAH为21%;SSc-PH再住院率未随时间下降,且住院期间死亡率更高。SSc-PH再住院的独立预测因素包括男性、年龄<60岁、 Medicare/Medicaid保险、较高Charlson/Deyo合并症指数和充血性心力衰竭。

要点

  • SSc-PH患者30天再住院率22%,与non-SSc PAH的21%相近。
  • 2010至2015年SSc-PH再住院率无变化,non-SSc PAH则下降。
  • SSc-PH再住院独立预测因素包括男性、年龄<60岁、医保类型、合并症指数和心衰。

核心结论

  • SSc-PH患者30天再住院常见,且住院期间死亡率高于non-SSc PAH患者。
  • 研究识别了SSc-PH再住院高危患者的特征因素。

研究设计与样本

  • 回顾性研究,使用医疗成本与利用项目-全国再住院数据库,通过ICD-9代码识别SSc-PH和non-SSc PAH住院。
  • 计算2010至2015年30天再住院率,比较组间特征并建立校正logistic回归模型。

主要发现

  • SSc-PH患者22,420例中4,846例(22%)发生至少一次30天再住院;non-SSc PAH患者49,254例中10,573例(21%)发生再住院。
  • 2010至2015年,non-SSc PAH再住院率从23%降至20%(p<0.001),SSc-PH再住院率从23%至23%无变化(p=0.77)。
  • SSc-PH患者较non-SSc PAH患者在索引住院期间(p=0.001)和再住院期间(p<0.001)死亡比例更高。
  • SSc-PH再住院患者较non-SSc PAH再住院患者更年轻且充血性心力衰竭比例更低。
  • SSc-PH再住院最常见主要诊断为感染,其次为呼吸系统疾病和心力衰竭。

关键数值与推荐

  • SSc-PH30天再住院独立预测因素:男性、年龄<60岁、Medicare或Medicaid保险、较高Charlson/Deyo合并症指数、充血性心力衰竭。

临床怎么用

  • 临床应关注具有男性、年龄<60岁、Medicare/Medicaid保险、高合并症指数和心衰等特征的SSc-PH患者,其30天再住院风险较高。
  • SSc-PH患者再住院常见原因为感染、呼吸系统疾病和心力衰竭,出院管理应针对性评估和干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To identify risk-factors for 30-day hospital readmission in systemic sclerosis pulmonary hypertension (SSc-PH) and to compare trends and characteristics of 30-day readmissions in SSc-PH versus non-SSc pulmonary arterial hypertension (non-SSc PAH). METHODS: In this retrospective study, we identified SSc-PH and non-SSc PAH hospitalizations using ICD-9 codes within the Healthcare Cost and Utilization Project-National Readmission Database. Thirty-day readmission rates were calculated between 2010 and 2015. Characteristics were compared using chi-square, Wilcoxon rank-sum, or two-sample t-tests between (A) SSc-PH patients with versus without readmission and (B) patients with ≥1 readmission with SSc-PH versus non-SSc PAH. Adjusted logistic regression models were generated for readmission in SSc-PH. RESULTS: 4,846 of 22,420 (22%) with SSc-PH and 10,573 of 49,254 (21%) with non-SSc PAH had ≥1 30-day readmission. Between 2010-2015, readmission rate decreased in non-SSc PAH (23% to 20%; p<0.001) and was unchanged in SSc-PH (23% to 23%; p = 0.77). In SSc-PH, independent predictors of 30-day readmission include male sex, age <60, Medicare or Medicaid, higher Charlson/Deyo comorbidity index, and congestive heart failure (CHF). A higher proportion of patients with SSc-PH (vs. non-SSc PAH) died during index hospitalizations (p = 0.001) and readmissions (p <0.001). Readmitted patients with SSc-PH (vs. non-SSc PAH) were younger and less often had CHF. In SSc-PH, the most common readmission primary diagnosis was infection, followed by respiratory and heart failure. CONCLUSION: In SSc-PH, 30-day readmission is frequent, and in-hospital deaths occur at a higher rate compared to those with non-SSc PAH. This study identifies factors that may characterize those with SSc-PH at highest risk for readmission.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Showalter K, Ma X, Pinheiro L, et al. Thirty-day hospital readmission in systemic sclerosis associated pulmonary hypertension: A nationwide study. Semin Arthritis Rheum. 2021. PMID: 33465591. doi:10.1016/j.semarthrit.2021.01.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。